Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
7.8
5.6
Journals
IJMS
Special Issues
Role of Cytokines and Their Receptors in Human Tumors and...
ijms-logo
Submit to Special Issue Submit Abstract to Special Issue Review for IJMS Propose a Special Issue

Journal Menu

► Journal Menu

Journal Browser

► Journal Browser
share announcement

Role of Cytokines and Their Receptors in Human Tumors and Immune-Regulation

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Immunology".

Deadline for manuscript submissions: 30 May 2024 | Viewed by 2958

Special Issue Editor

Prof. Dr. Spaska Stanilova

E-Mail Website
Guest Editor
Department of Molecular Biology, Immunology and Medical Genetics, Medical Faculty, Trakia University, Armeiska 11 Street, Stara Zagora 6000, Bulgaria
Interests: gene polymorphism; colorectal cancer; cytokine; immune modulation

Special Issue Information

Dear Colleagues,

Cytokines are the main signaling molecules for the development of the immune response. After binding to their specific receptors on different types of immune cells, signal transduction pathways are activated, affecting the functional activity, proliferation, and differentiation of target cells. These processes concern both immune and tumor cells, as well as the development of tumor growth and metastasis. Further understanding of the induced cytokine signature in the tumor microenvironment will provide deeper insight into the molecular mechanisms of immune regulation during tumorigenesis. These new data can provide important information regarding the practical approach to the treatment of different tumor types.

This Special Issue will provide a platform for the newest scientific research concerning the molecular mechanisms of the regulation of cytokines and their receptors in immune cells in the tumor milieu. Original articles and reviews on signal transduction involving cytokines and their receptors, molecular genetics and epigenetics regulation, cell biology and immunology, and related fields, focusing on tumor development and metastasis, are welcome.

Prof. Dr. Spaska Stanilova
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cytokines
  • cytokine receptors
  • immune regulation
  • cytokine expression regulation
  • tumorogenesis
  • tumor development

Published Papers (2 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

Jump to: Review

19 pages, 2379 KiB  
Article
Deregulated Expression of IL-37 in Patients with Bladder Urothelial Cancer: The Diagnostic Potential of the IL-37e Isoform
by Maria Papasavva, Styliana Amvrosiou, Katerina-Marina Pilala, Konstantinos Soureas, Panayiota Christodoulou, Yuan Ji, Konstantinos Stravodimos, Damo Xu, Andreas Scorilas, Margaritis Avgeris and Maria-Ioanna Christodoulou
Int. J. Mol. Sci. 2023, 24(11), 9258; https://doi.org/10.3390/ijms24119258 - 25 May 2023
Cited by 2 | Viewed by 1512
Abstract
Cellular and molecular immune components play a crucial role in the development and perpetuation of human malignancies, shaping anti-tumor responses. A novel immune regulator is interleukin-37 (IL-37), already shown to be involved in the inflammation associated with the pathophysiology of many human disorders, [...] Read more.
Cellular and molecular immune components play a crucial role in the development and perpetuation of human malignancies, shaping anti-tumor responses. A novel immune regulator is interleukin-37 (IL-37), already shown to be involved in the inflammation associated with the pathophysiology of many human disorders, including cancer. The interplay between tumor and immune cells is of great importance, especially for highly immunogenic tumors such as bladder urothelial carcinoma (BLCA). This study aimed to investigate the potential of IL-37 and its receptor SIGIRR (single immunoglobulin IL-1-related receptor) to serve as prognostic and/or diagnostic markers in patients with BLCA. To this end, a series of bioinformatics tools processing -omics datasets and specifically designed qPCR assays on human BLCA tumors and cancer cell lines were utilized. Bioinformatics analysis revealed that IL-37 levels correlate with BLCA tumor development and are higher in patients with longer overall survival. Furthermore, mutations on SIGIRR are associated with enhanced infiltration of the tumor by regulatory T cells and dendritic cells. Based on the qPCR validation experiments, BLCA epithelial cells express the IL-37c and IL-37e isoforms, while the latter is the predominant variant detected in tumor biopsies, also associated with higher grade and the non-muscle-invasive type. This is the first time, to the best of our knowledge, that IL-37 and SIGIRR levels have been assessed in BLCA tumor lesions, and associations with pathological and survival parameters are described, while a transcript variant-specific signature is indicated to have a diagnostic potential. These data strongly indicate the need for further investigation of the involvement of this cytokine and interconnected molecules in the pathophysiology of the disease and its prospective as a therapeutic target and biomarker for BLCA. Full article
(This article belongs to the Special Issue Role of Cytokines and Their Receptors in Human Tumors and Immune-Regulation)
►▼ Show Figures

Figure 1

Review

Jump to: Research

17 pages, 1571 KiB  
Review
Navigating the Cytokine Seas: Targeting Cytokine Signaling Pathways in Cancer Therapy
by Noyko Stanilov, Tsvetelina Velikova and Spaska Stanilova
Int. J. Mol. Sci. 2024, 25(2), 1009; https://doi.org/10.3390/ijms25021009 - 13 Jan 2024
Cited by 1 | Viewed by 1055
Abstract
Cancer remains one of the leading causes of morbidity and mortality worldwide, necessitating continuous efforts to develop effective therapeutic strategies. Over the years, advancements in our understanding of the complex interplay between the immune system and cancer cells have led to the development [...] Read more.
Cancer remains one of the leading causes of morbidity and mortality worldwide, necessitating continuous efforts to develop effective therapeutic strategies. Over the years, advancements in our understanding of the complex interplay between the immune system and cancer cells have led to the development of immunotherapies that revolutionize cancer treatment. Cytokines, as key regulators of the immune response, are involved in both the initiation and progression of cancer by affecting inflammation and manipulating multiple intracellular signaling pathways that regulate cell growth, proliferation, and migration. Cytokines, as key regulators of inflammation, have emerged as promising candidates for cancer therapy. This review article aims to provide an overview of the significance of cytokines in cancer development and therapy by highlighting the importance of targeting cytokine signaling pathways as a potential therapeutic approach. Full article
(This article belongs to the Special Issue Role of Cytokines and Their Receptors in Human Tumors and Immune-Regulation)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-2
Back to TopTop